Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a ...
Norovirus care results in about $28M in yearly costs for Veterans Health Administration, study finds
Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
There are currently no approved vaccines or treatments for norovirus infection Cocrystal’s CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by ...
The highly contagious norovirus – popularly known as "stomach flu" or the "winter vomiting bug" – is now surging through the U.S. The number of outbreaks is up significantly over previous years, ...
Detailed price information for Cocrystal Pharma Inc (COCP-Q) from The Globe and Mail including charting and trades.
As 2025 begins, norovirus, also known as the stomach flu, is surging across the United States. The highly contagious virus which causes unpleasant bouts of vomiting and diarrhea is causing a record ...
The winter of 2025 has witnessed an unprecedented surge in norovirus cases across the nation, with infection rates surpassing all previous records since monitoring began. The Centers for Disease ...
Norovirus outbreaks are popping up around the United States, causing concern during a winter when other illnesses also seem ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback